Musculoskeletal Pains Market Analysis Growth Opportunities and Demand Drives by 2021 to 2031Posted by pooja on August 23rd, 2022  The global muscle wasting disorder market is fueled primarily by the rising adherence to a sedentary lifestyle in developed regions. Due to the prosperity of regions such as North America and Europe, the number of sedentary office jobs has risen steadily. This has led to a proliferation of muscular and spinal disorders, including muscle wasting disorders. The rising number of urban citizens succumbing to posture-related disorders in developed regions is thus likely to remain a key driver for the global muscle wasting disorder market in the coming years. Musculoskeletal pains refers to the acute or chronic pains of soft tissues or organs, which can be caused due to an injury, falls, jerking movements, falls, sprains, fractures, dislocations, and overuse of the organ. For instance, lower back pain is a common work related musculoskeletal pain that is caused due to prolonged immobilization or poor posture. Apart from Novasratis AG and Nordic Bioscience mentioned above, some of the other major market players in global musculoskeletal pains market are DURECT Corporation, Zogenix, Inc., Dainippon Sumitomo Pharma Co., Ltd., BioDelivery Sciences International, Inc., Pfizer, Inc., Collegium Pharmaceutical, Inc., Teva Pharmaceutical Industries, Limited, Chelsea Therapeutics, Inc., TransPharma Medical, Ltd. and Purdue Pharma L.P. Get Sample Copy Of This Report: https://www.tmrresearch.com/sample/sample?flag=B&rep_id=117
About TMR Research Contact: Like it? Share it! More by this author |